Against the backdrop of the recent $120 million in damages awarded to Apple over Samsung's alleged patent-infringement earlier this month, Apple has filed a motion seeking a retrial and get a bigger compensation amount.
In its motion filed in the court on Friday, Apple has put forth an argument for a retrial on the damages amount. The $119.6 million judgment which Apple won against Samsung marks a very small damages award for the company, especially since it was seeking more than $2 billion in damages.
Other than a higher compensation, Apple is also seeking a permanent US sales ban against Samsung devices which have been found to violate Apple's patents, including the slide-to-unlock feature and data detectors.
The Samsung devices against which Apple has sought a permanent injunction include the Galaxy Nexus, Galaxy Note, Galaxy Note 2, Galaxy S II, Galaxy S II Epic 4G Touch, Galaxy S II Skyrocket, Galaxy S III, Admire, and Stratosphere.
Along with the above-mentioned handsets, Apple is also seeking a ban on software and code which are capable of implementing the infringed features. Towards that end, Apple said in its court document that it will "suffer irreparable harm if Samsung continues its use of the Infringing Features."
In a recent announcement, Amazon has revealed that it has rolled out an update to its Echo digital assistant, to ensure that organizing plans and schedules becomes much more convenient for Echo users.
The update to the Amazon Echo wireless...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
In a Friday announcement, Fiat Chrysler said that it is recalling nearly 1.1 million vehicles due to a transmission shifter issue. The automaker said that the problem which has resulted in the recall can cause the affected vehicles to roll away...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In an announcement made via a blog post on Thursday,...
In a Friday announcement, Fiat Chrysler said that it is...
In a recent announcement, Sega has revealed that its...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).